HedgeCo.Net — Robinhood Ventures Fund II priced 8 million common shares at $25 on Thursday, bringing the business-development company to a $225.5 million fund size — $255.5 million if underwriters exercise a 30-day option for 1.2 million more shares — and began trading on the NYSE under ticker RVII. The offering is scheduled to close Friday. Shares opened at $22.50, a 10% discount to the IPO price on day one. For allocators watching the democratization of private markets, that print is the story: retail can now buy a listed sleeve of early-stage venture, and the market immediately applied a closed-end haircut.
The vehicle is a 1940 Act BDC advised by a Robinhood Markets subsidiary, designed to give non-accredited investors exposure to a diversified book of earliest-stage private companies, with a stated focus on current or former Y Combinator participants and companies with a YC founder. Quartz reported the fund already holds 80 private companies. Goldman Sachs was lead bookrunner; Citigroup, J.P. Morgan, UBS, and Wells Fargo Securities were joint bookrunners. Robinhood’s first listed venture vehicle, Fund I, began trading March 6 with a late-stage mandate. RVII is the seed-stage sequel, and the speed of the second listing is itself a product decision: Robinhood is trying to industrialize listed access to private companies the way it industrialized commission-free brokerage.
Institutional LPs should not confuse this with a new competitor for Sequoia or Lightspeed mandates. A $225 million BDC that must mark, disclose, and trade is a different animal from a 10-year drawdown fund with information rights and reserve capital. The listed wrapper solves a distribution problem — RIAs and retail can buy it in a brokerage account — and creates a valuation problem the private market has spent years avoiding. Day-one trading at $22.50 against a $25 IPO is the same species of discount Pershing Square USA is fighting in the hedge-fund complex. Supply of listed private-market paper is being created faster than a dedicated buyer base is forming.
Second-order, RVII sits at the intersection of three crowded trades: retail alternatives, the BDC wrapper, and YC-correlated early-stage beta. If the share class holds a discount, the vehicle can become a secondary-market expression of seed venture rather than a compounding NAV product, which would be useful for hedge funds that want to short or arbitrage private-market access and unhelpful for the buy-and-hold RIA the prospectus is written for. If Robinhood can keep issuing sibling funds — late-stage, early-stage, and whatever comes next — the firm is building a listed private-markets shelf. The Friday close is a settlement date. The allocator question is whether the next twelve months of RVII trading look like a venture portfolio or like another closed-end fund in search of a bid.